Literature DB >> 3881741

Circulating immune complexes in Kawasaki syndrome.

W H Mason, S C Jordan, R Sakai, M Takahashi, B Bernstein.   

Abstract

Sera of 42 patients with Kawasaki syndrome were evaluated for the presence of circulating immune complexes (CICs) by Raji cell radioimmune and C1q solid phase assays. Overall 69% of sera tested were positive by one or both assays, 52% by Raji cell radioimmune and 48% by C1q solid phase assay. CICs were detected most frequently 2 to 4 weeks after the onset of illness, but their presence did not correlate with the clinical severity of the illness or incidence of coronary artery aneurysms. Antibody to mite antigen was found in only 2 of 30 patients tested, and only one of these had CICs. CICs are frequently associated with Kawasaki syndrome, but their role in its pathogenesis remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881741     DOI: 10.1097/00006454-198501000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  16 in total

1.  Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

Authors:  S Kobayashi; N Wada; M Kubo
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

2.  Early decreased plasma levels of factor B and C5a are important biomarkers in children with Kawasaki disease.

Authors:  Qing-Mei Zou; Xiao-Hui Li; Rui-Xia Song; Nan-Ping Xu; Ting Zhang; Ming-Ming Zhang; Yao Lin; Lin Shi; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-05-04       Impact factor: 3.756

Review 3.  Kawasaki disease: recent advances.

Authors:  M Levin; E J Tizard; M J Dillon
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

Review 4.  Kawasaki syndrome: lessons for Britain.

Authors:  J G Bissenden; S Hall
Journal:  BMJ       Date:  1990-04-21

5.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.

Authors:  D Y Leung; T Collins; L A Lapierre; R S Geha; J S Pober
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Kawasaki disease associated with ulcerative colitis.

Authors:  J Doerfer; S Wässer
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

Review 7.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

8.  Kawasaki disease: monitoring of circulating immune complexes.

Authors:  E Salo; R Kekomäki; P Pelkonen; O Ruuskanen; M Viander; O Wagner
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

9.  The case of Kawasaki disease after rituximab infusion triggered by human anti-chimeric antibodies.

Authors:  Masayuki Sato; Masayoshi Yamada; Mika Nakajima; Yudai Miyama; Hirotsugu Kitayama
Journal:  CEN Case Rep       Date:  2020-06-13

10.  Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.

Authors:  D Y Leung; J C Burns; J W Newburger; R S Geha
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.